Methylprednisolone Unknown Status Phase 2 Trials for Primary Central Nervous System Lymphoma (PCNSL) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00455286a Phase II Study in Primary Central Nervous System Lymphoma